Dora B. Madhura - Concepedia

Author

Dora B. Madhura

University of Tennessee Health Science Center

Also Known As

D B Madhura, Dora B Madhura, Dora B. Madhura, Dora Babu Madhura

Publications

343

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center St. Jude Children's Research Hospital Colorado State University

About

Dora B. Madhura is an author at University of Tennessee Health Science Center specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	313
2	Biochemistry	2	2	26
3	Health Sciences	1	1	32
4	Natural Sciences	1	1	16
5	Chemical Biology	1	1	16

Dora B. Madhura

Publications

332

Citations

H-Index

Page 1

	Year	Citations
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux Richard Lee, Julian G. Hurdle, Jiuyu Liu, Nature Medicine Pharmaceutical ScienceMedicineSemisynthetic Antituberculosis AgentsPharmacological AgentNew Class	2014	192
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties Rakesh Rakesh, David F. Bruhn, Dora B. Madhura, Bioorganic & Medicinal Chemistry Pharmaceutical ScienceAntitubercular Nitrofuran IsoxazolinesMedicinePharmacotherapyAntimicrobial Chemotherapy	2012	46
Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis Rakesh Rakesh, David F. Bruhn, Michaël Scherman, PLoS ONE Oral BioavailabilityVivo EfficacyPentacyclic NitrofuransAntimicrobial ChemotherapyDrug Resistance	2014	32
Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections David F. Bruhn, Samanthi L. Waidyarachchi, Dora B. Madhura, Science Translational Medicine	2015	19
Evaluation of a <scp>DTPA</scp> Prodrug, <scp>C2E5</scp> as an Orally Bioavailable Radionuclide Decorporation Agent Matthew P. Sadgrove, Marina G. D. Leed, Shraddha Shapariya, Drug Development Research Molecular PharmacologyPharmaceutical SciencePreclinical Drug EvaluationMedicineRadiopharmaceuticals	2012	17
Phase II metabolic pathways of spectinamide antitubercular agents: a comparative study of the reactivity of 4-substituted pyridines to glutathione conjugation Dora B. Madhura, Jiuyu Liu, Bernd Meibohm, MedChemComm Pharmaceutical ScienceBioorganic ChemistryChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2015	16
Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis Pavan Vaddady, Ashit Trivedi, Chetan Rathi, European Journal of Pharmaceutical Sciences Antimicrobial SusceptibilityBiochemistryAntibioticsMedicineAntibiotic Adjuvant	2018	10

Page 1